Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis

Gut. 2007 Mar;56(3):443-4. doi: 10.1136/gut.2006.106021.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Anti-Obesity Agents / therapeutic use*
  • Fatty Liver / drug therapy*
  • Female
  • Humans
  • Lactones / therapeutic use*
  • Liver Cirrhosis / drug therapy*
  • Male
  • Middle Aged
  • Obesity / complications
  • Orlistat
  • Treatment Outcome
  • Weight Loss / drug effects*

Substances

  • Anti-Obesity Agents
  • Lactones
  • Orlistat